Follow
Ariane Herrick
Ariane Herrick
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ...
Arthritis & Rheumatism 65 (11), 2737-2747, 2013
40342013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ...
Annals of the Rheumatic Diseases 72 (11), 1747 - 1755, 2013
40342013
Update of EULAR recommendations for the treatment of systemic sclerosis
O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ...
Annals of the Rheumatic Diseases 76 (8), 1327-1339, 2017
8832017
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist
JH Korn, M Mayes, M Matucci Cerinic, M Rainisio, J Pope, E Hachulla, ...
Arthritis & Rheumatism 50 (12), 3985-3993, 2004
8372004
A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the …
RK Hoyles, RW Ellis, J Wellsbury, B Lees, P Newlands, NSL Goh, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
7992006
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ...
Annals of the rheumatic diseases 72 (11), 1747-1755, 2013
569*2013
Pathogenesis of Raynaud's phenomenon
AL Herrick
Rheumatology 44 (5), 587-596, 2005
5192005
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192
CP Denton, PA Merkel, DE Furst, D Khanna, P Emery, VM Hsu, N Silliman, ...
Arthritis & Rheumatism 56 (1), 323-333, 2007
4752007
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
TRDJ Radstake, O Gorlova, B Rueda, JE Martin, BZ Alizadeh, ...
Nature genetics 42 (5), 426, 2010
4182010
Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome
G Rice, WG Newman, J Dean, T Patrick, R Parmar, K Flintoff, P Robins, ...
The American Journal of Human Genetics 80 (4), 811-815, 2007
3602007
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
AL Herrick
Nature Reviews Rheumatology 8 (8), 469, 2012
3102012
Correction: Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
O Gorlova, JE Martin, B Rueda, BPC Koeleman, J Ying, M Teruel, ...
PLoS genetics 7 (8), 2011
237*2011
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
O Gorlova, JE Martin, B Rueda, BPC Koeleman, J Ying, M Teruel, ...
PLoS genetics 7 (7), e1002178, 2011
2372011
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis
MD Mayes, L Bossini-Castillo, O Gorlova, JE Martin, X Zhou, WV Chen, ...
The American Journal of Human Genetics 94 (1), 47-61, 2014
2202014
Interferon‐α does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double‐blind, placebo‐controlled trial
CM Black, AJ Silman, AI Herrick, CP Denton, H Wilson, J Newman, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1999
2171999
Seventeen-point dermal ultrasound scoring system—a reliable measure of skin thickness in patients with systemic sclerosis
TL Moore, M Lunt, B McManus, ME Anderson, AL Herrick
Rheumatology 42 (12), 1559-1563, 2003
2092003
BSR and BHPR guideline for the treatment of systemic sclerosis
CP Denton, M Hughes, N Gak, J Vila, MH Buch, K Chakravarty, ...
Rheumatology 55 (10), 1906-1910, 2016
1722016
Vascular function in systemic sclerosis
AL Herrick
Current opinion in rheumatology 12 (6), 527-533, 2000
1562000
HLA-DRB1* 11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
MJ Ombrello, EF Remmers, I Tachmazidou, A Grom, D Foell, JP Haas, ...
Proceedings of the National Academy of Sciences 112 (52), 15970-15975, 2015
1532015
Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland
AL Herrick, H Ennis, M Bhushan, AJ Silman, EM Baildam
Arthritis Care & Research: Official Journal of the American College of …, 2010
1532010
The system can't perform the operation now. Try again later.
Articles 1–20